All News

An experimental program shows promise for better integration of screening for and treating alcohol use disorder into primary care practice.

ACC 2023. A large study found increased risk for MI regardless of age and detected particularly heightened risk among women and persons with diabetes who have insomnia.

ACC 2023. New study found cognitive behavioral therapy delivered via mobile app significantly reduced HbA1c and need for antihyperglycemic intensification compared to use of a control app.

Food addiction researcher Ashley Gearhardt, PhD, links survey data on addictive behavior in older adults to the dawn of aggressive food marketing.

The first-of-its kind combination home-based test matched lab-based PCR tests for identification of influenza A and B and COVID-19.

Your daily dose of clinical news you may have missed.

ACC 2023. Increasing rates of adverse pregnancy outcome over the last decade are largely attributable to a woman’s health status before she gets pregnant, rather than age, according to new research.

Train your staff well, says this expert in business texting solutions, and make sure to develop and use appropriate checks and balances.

The association between air pollution and Parkinson disease was found strongest in the Rocky Mountain region and the Mississippi-Ohio River Valley in a new study.

ACC 2023. Daily marijuana users were 34% more likely to have coronary artery disease than never-users, according to new research.

Even after mild cases of COVID-19, imaging found evidence of tissue atrophy and aberrant connectivity in persons with long-COVID-related anxiety, depression.

For a health care systems that is " wildly out of balance and in critical need of reform,” the tracking tool can benchmark and measure change over time.

Find key takeaways from the US Centers for Disease Control and Prevention's latest Youth Risk Behavior Survey in our new slideshow.

Many older adults show symptoms of food addiction, a new survey found. Is it time to start screening? A primary care physician considers the feasibility and the value.

AAAAI 2023. The TSLP inhibitor was superior to placebo in 2 post hoc analyses of the PATHWAY and NAVIGATOR clinical trials.

Your daily dose of clinical news you may have missed.

Future studies may consider PARS the new gold standard in predicting pediatric asthma risk, said study authors.

AAAAI 2023. Pandemic prescribing rates for systemic corticosteroids increased from Alpha to Delta to Omicron waves of COVID-19 but hospitalizations have dropped, study finds.